Connect
MJA
MJA

Safety of hormone replacement therapy after mastectomy

Christopher B Del Mar, Paul P Glasziou, Anneliese B Spinks, Sharon L Sanders and Deborah J Hilton
Med J Aust 2002; 176 (6): . || doi: 10.5694/j.1326-5377.2002.tb04411.x
Published online: 18 March 2002

After mastectomy, chemotherapy and radiotherapy for high-grade ductal carcinoma with nodal involvement and lymphatic infiltration, a 48-year-old woman had premature menopause, with symptoms of loss of libido. Her general practitioner wanted to know how safe and effective hormone replacement therapy (HRT) would be for this patient.


  • Centre for General Practice, Medical School, University of Queensland, Herston, QLD.


Correspondence: c.delmar@cgp.uq.edu.au

  • 1. Guidozzi F. Estrogen replacement therapy in breast cancer survivors. Int J Gynaecol Obstet 1999; 64: 59-63.
  • 2. Wile AG, Opfell RW, Margileth DA. Hormone replacement therapy in previously treated breast cancer patients. Am J Surg 1993; 165: 372-375.
  • 3. DiSaia PJ, Grosen EA, Odicino F, et al. Replacement therapy for breast cancer survivors. A pilot study. Cancer 1995; 76: 2075-2078.
  • 4. DiSaia PJ, Grosen EA, Kurosaki T, et al. Hormone replacement therapy in breast cancer survivors: a cohort study. Am J Obstet Gynecol 1996; 164: 1494-1498.
  • 5. Ursic-Vrscaj M, Bebar S. A case-control study of hormone replacement therapy after primary surgical breast cancer treatment. Eur J Surg Oncol 1999; 25: 146-151.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.